COZAAR Plus
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for COZAAR Plus, covering 2024-08-15 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325) [Phase 3]